Skip to main content
TipRanks
Go Ultimate75% OFF

Wellnex Life Ltd (22W0) AI Stock Analysis

0 Followers
DE:22W0

Wellnex Life Ltd

(Frankfurt:22W0)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue ReboundThe strong two-year revenue rebound indicates improving commercial scale across Wellnex’s consumer health portfolio. Continued top-line expansion can broaden distribution, support operating leverage, and provide a larger base from which the company may eventually build sustainable profitability.
Negative Factors
Weak ProfitabilityVery low gross margin and continuing negative EBIT, EBITDA, and net income show that revenue growth has not yet translated into a profitable operating model. Unless margins recover, Wellnex may struggle to fund expansion internally or convert increased sales into durable earnings.

Wellnex Life Ltd (22W0) vs. iShares MSCI Germany ETF (EWG)

-100%-80%-60%-40%-20%0%20%DE:22W0-71.76%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 2.69M
Dividend Yield
―
Average Volume (3M)
―
Price to Earnings (P/E)
-0.9
Beta (1Y)
1.82
Revenue Growth
2.54%
EPS Growth
87.72%
Country
Germany
Employees
3
Sector
Consumer Defensive
Sector Strength
62
Industry
Packaged Foods

Wellnex Life Ltd Business Overview & Revenue Model

Company Description

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pai...

Wellnex Life Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

DE:22W0 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
AU:BUBAU:BUB48NeutralAUD 70.72M-15.19-11.08%―9.08%-183.87%
AU:NGSAU:NGS46NeutralAUD 19.28M-0.01-130.72%―-33.05%94.22%
AU:NUCAU:NUC37UnderperformAUD 9.57M-1.28-88.51%―11.96%-81.99%
AU:HCTAU:HCT29UnderperformAUD 12.14M-3.791795.70%―0.72%-486.96%

* Consumer Defensive Sector Average

Performance Comparison

-75%-50%-25%0%25%DE:22W0AU:BUBAU:NUCAU:HCTAU:NGSDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:22W0 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:22W0Wellnex Life Ltd0.02-0.06-72.09%
AU:BUBBubs Australia Ltd.0.08-0.06-43.57%
AU:NUCNuchev Pty Ltd0.06-0.10-63.03%
AU:HCTHolista Colltech Limited0.03-0.06-63.33%
AU:NGSNutritional Growth Solutions Ltd.0.020.005.26%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.